Genetics of IPF - Screening Study for Family Members



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:40 - Any
Updated:4/17/2018
Start Date:January 18, 2018
End Date:September 29, 2021
Contact:Julia P Becker, MHS
Email:julia.powers@ucdenver.edu
Phone:303-724-6539

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Idiopathic Pulmonary Fibrosis, a Disease Initiated by Mucociliary Dysfunction

This study seeks to screen first degree family members of people with Idiopathic Pulmonary
Fibrosis (IPF) for the earliest signs of lung fibrosis.

The purpose of this study is to explore genetic factors associated with the development of
pulmonary fibrosis. The investigators aim is to identify and explore genetic loci that affect
development of pulmonary fibrosis and also explore related environmental exposures.
Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases under the
broader umbrella of idiopathic interstitial pneumonias (IIP). The investigators hypothesize
that inherited genetic factors are associated with pulmonary fibrosis. To investigate the
genetics of pulmonary fibrosis, the investigators plan to enroll individuals with pulmonary
fibrosis and their family members.

Inclusion Criteria:

- Age at least 40 years old

- Family member diagnosed with IPF

Exclusion Criteria:

- No family member with IPF
We found this trial at
1
site
University of Colorado Anschutz Medical Campus
13001 E 17th Pl
Aurora, Colorado 80045
(303) 724-5000
Phone: 303-724-4025
University of Colorado Anschutz Medical Campus Located in the Denver metro area near the Rocky...
?
mi
from
Aurora, CO
Click here to add this to my saved trials